Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Nutrition Intervention
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Oleoylethanolamide (OEA)
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Oligo Fucoidan
Biotech Pharmaceutical Co.,
NSCLC Stage IV
1 trial -
On-site radiologist
International Peace Maternity and Child Health Hospital
Tuberculosis
1 trial -
Ondansetron
United Therapeutics Europe Ltd
Vomiting of Pregnancy
1 trial -
Ondansetron (Zofran)
United Therapeutics Europe Ltd
Itching
1 trial -
Only conventional drug therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Artery Hypertension
1 trial -
Open Placebo
BRIGHT MINDS BIOSCIENCES INC.
Acute Pain
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial -
Oral fluid
Hospital Authority, Hong Kong
Osteoarthritis, Knee
1 trial -
Oral nutritional supplementation (ONS)
United Therapeutics Europe Ltd
Muscle Wasting
1 trial -
Oxygen
United Therapeutics Europe Ltd
Critical Illness
1 trial -
Oxytocin
United Therapeutics Europe Ltd
Posttraumatic Stress Disorder
1 trial -
P2Y12 antagonist monotherapy
Vera Therapeutics
Coronary Artery Disease
1 trial -
PCSK9 inhibitor
The First People's Hospital of Lianyungang
Intracranial Artery Stenosis
1 trial -
PCSK9 inhibitor (PCSK9i)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
PSMA PET/CT
The First People's Hospital of Lianyungang
Prostate Adenocarcinoma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Partially Hydrolyzed Whey Protein Formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mild Allergic Symptoms in Infants
1 trial -
Pastured Livestock Diet
United Therapeutics Europe Ltd
Omega 3 Fatty Acids
1 trial -
Peanuts
United Therapeutics Europe Ltd
Prediabetes
1 trial -
Peginterferon Ξ±-2b injection
The First People's Hospital of Lianyungang
Condylomata Acuminata
1 trial -
Peginterferon Ξ±-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources